Loading…
Reported covered position: Assistant to the Chief of Staff, Sen. Hagan
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Health and pharmaceutical policies before the Congress and the Administration. S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act, all provisions related to supply chain for medical products and mitigating U.S. medicine shortages
Health and pharmaceutical policies before the Congress. S. 4348, FDASLA Act of 2022, all provisions related to fees related to generic drugs.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2026 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
2026 · second_quarter · Q2
Trade policies impacting domestic generic pharmaceutical manufacturing
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2026 · first_quarter · Q1
Trade policies impacting domestic generic pharmaceutical manufacturing
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · fourth_quarter · Q4
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · second_quarter · Q2
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · first_quarter · Q1
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2024 · fourth_quarter · Q4
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2024 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2024 · second_quarter · Q2
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2024 · first_quarter · Q1
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2023 · fourth_quarter · Q4
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2023 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2023 · second_quarter · Q2
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues before the Congress
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
IKEA RETAIL US (FORMERLY KNOWN AS IKEA INDIRECT MATERIAL & SERVICES, LLC) via APCO WORLDWIDE LLC
2023 · second_quarter · Q2
Economic development in the U.S.
Sustainability practices and recycling definitions
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
IKEA RETAIL US (FORMERLY KNOWN AS IKEA INDIRECT MATERIAL & SERVICES, LLC) via APCO WORLDWIDE LLC
2023 · first_quarter · Q1
Sustainability practices and recycling definitions
Economic development in the U.S.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2023 · first_quarter · Q1
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues before the Congress
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2022 · fourth_quarter · Q4
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues before the Congress.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2022 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues before the Congress.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2022 · second_quarter · Q2
Health and pharmaceutical policies before the Congress. S. 4348, FDASLA Act of 2022, all provisions related to fees related to generic drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2022 · first_quarter · Q1
Health and pharmaceutical policies before the Congress and the Administration. S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act, all provisions related to supply chain for medical products and mitigating U.S. medicine shortages
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2022 · first_quarter · RR
Health and pharmaceutical policies before the Congress and the Administration